Oral pathogen candida in patients under antineoplastic therapies
DOI:
https://doi.org/10.17533/udea.rfo.v30n1a9Keywords:
neoplasia, cancer, candidiasis, Candida antineoplastic treatment, Candida, antineoplastic treatment, infectionAbstract
Cancer control treatments are aimed at prolonging patient survival, but they also trigger inevitable and irreversible side effects, often infectious in nature, complicating the prognosis of the oncological disease. These include the pathogenic behavior of Candida, with Albicans being its most common species in the oral mucosa. Albicans is considered a commensal fungus that, as a result of the neutropenia resulting from antineoplastic therapies, behaves as an opportunistic entity causing candidiasis. This fungal infection has aggravating factors for the patient, such as xerostomia and hyposalivation, infections like dental caries, and other factors such as improper oral hygiene. Several consulted authors highlight the presence of Candida, its different species and oral candidiasis as a microorganism and classic opportunistic infection in immunosuppressed patients, and even more in those subjected to antineoplastic treatments. The aim of this review is to describe the pathogenic behavior of Candida in the oral mucosa of patients under antineoplastic treatments.
Downloads
References
Teoh F, Pavelka N. How chemotherapy increases the risk of systemic candidiasis in cancer patients: current
paradigm and future directions. Pathogens. 2016; 5(1): pii: E6. https://doi.org/10.3390/pathogens5010006
Rodríguez-Leguizamón G, Fiori A, López LF, Gómez BL, Parra-Giraldo CM, Gómez-López A et al.
Characterising atypical Candida albicans clinical isolates from six third-level hospitals in Bogotá, Colombia.
BMC Microbiol. 2015; 15(1): 199. DOI: https://doi.org/10.1186/s12866-015-0535-0
Villanueva Reyes J, Arenas R. Candidiasis mucocutánea. Una revisión. Rev Mex Micol. 2007; 25: 91-104.
De-Sousa LV, Santos VL, de-Souza-Monteiro A, Dias-Souza MV, Marques SG, de-Faria ES et al. Isolation
and identification of Candida species in patients with orogastric cancer: susceptibility to antifungal drugs,
attributes of virulence in vitro and immune response phenotype. BMC Infect Dis. 2016; 23; 16(1): 86.
DOI: https://doi.org/10.1186/s12879-016-1431-4
Yamashita K, Ohara M, Kojima T, Nishimura R, Ogawa T, Hino T et al. Prevalence of drug-resistant
opportunistic microorganisms in oral cavity after treatment for oral cancer. J Oral Sci. 2013; 55(2): 145-55.
Komeno Y, Uryu H, Iwata Y, Hatada Y, Sakamoto J, Iihara K et al. Esophageal candidiasis as the
initial manifestation of acute myeloid leukemia. Intern Med. 2015; 54(23): 3087-92. DOI: https://doi.
org/10.2169/internalmedicine.54.4613
Alt-Epping B, Nejad RK, Jung K, Gross U, Nauck F. Symptoms of the oral cavity and their association with
local microbiological and clinical findings—a prospective survey in palliative care. Support Care Cancer.
; 20(3): 531-7. https://doi.org/10.1007/s00520-011-1114-z
Singh A, Verma R, Murari A, Agrawal A. Oral candidiasis: an overview. J Oral Maxillofac Pathol. 2014;
(Suppl 1): S81-5. DOI: https://doi.org/10.4103/0973-029X.141325
Palacios CP, Gómez LM, Cardona N. Candidiasis mucocutánea: espectro clínico. Rev Asoc Colomb
Dermatol. 2011; 19: 239-44.
Del-Palacio A, Villar J, Alhambra A. Epidemiología de las candidiasis invasoras en población pediátrica
y adulta. Rev Iberoam Micol. 2009; 26(1): 1-93. DOI: https://doi.org/10.1016/S1130-1406(09)70002-6
Patil S, Rao RS, Majumdar B, Anil S. Clinical Appearance of Oral Candida Infection and Therapeutic
Strategies. Front Microbiol. 2015; 6: 1391. DOI: https://doi.org/10.3389/fmicb.2015.01391
Kakati B, Kotwal A, Biswas D, Sahu S. Fluconazole Resistant Candida Oesophagitis in Immunocompetent
Patients: Is Empirical Therapy Justifiable? J Clin Diagn Res. 2015; 9(12): DC16-8. DOI: https://doi. org/10.7860/JCDR/2015/15171.6975
Prieto D, Pla J. Distinct stages during colonization of the mouse gastrointestinal tract by
Candida albicans. Front Microbiol. 2015; 6: 792. DOI: https://doi.org/ 10.3389/fmicb.2015.00792
Jung DS, Farmakiotis D, Jiang Y, Tarrand JJ, Kontoyiannis DP. Uncommon Candida Species Fungemia
among Cancer Patients, Houston, Texas, USA. Emerg Infect Dis. 2015; 21(11): 1942-50. DOI: https://doi.
org/10.3201/eid2111.150404
Lim S, Kil TJ, Kim HR, Han S, Rha SY. A case of gingival candidiasis with bone destruction on gastric cancer
patient receiving cytotoxic chemotherapy. Case Rep Oncol Med. 2014; 2014: 145394. DOI: https://doi.
org/10.1155/2014/145394
Xu L, Zhang H, Liu J, Chen X. Investigation of the oral infections and manifestations seen in patients with
advanced cancer. Pak J Med Sci. 2013; 29(5): 1112-5.
Gall F, Colella G, Di Onofrio V, Rossiello R, Angelillo IF, Liguori G. Candida spp in oral cancer and oral
precancerous lesions. New Microbiol. 2013; 36(3): 283-8.
Shrestha M, Boaz K, Srikant N, Shakya A. An assessment of Candida colonization and species differentiation
in head and neck cancer patients receiving radiation. J Nepal Health Res Counc. 2014; 12(28): 156-61.
Modrzewska B, Kurnatowski P. Adherence of Candida sp. to host tissues and cells as one of its pathogenicity
features. Ann Parasitol. 2015; 61(1): 3-9.
Galipothu S, Kalawat U, Ram R, Kishore C, Sridhar AV, Chaudhury A et al. Cutaneous fungal infection in a
renal transplantation patient due to a rare fungus belonging to order Pleosporales. Indian J Med Microbiol.
; 33(1): 165-7. https://doi.org/10.4103/0255-0857.148435
Chambô-Filho A, Souza-Filho JB, Pignaton CC, Zon I, Fernandes AS, Cardoso LQ. Chronic mucocutaneous
candidiasis: a case with exuberant cutaneous horns in nipples. An Bras Dermatol. 2014; 89(4): 641-4.
Hirakawa MP, Martinez DA, Sakthikumar S, Anderson MZ, Berlin A, Gujja S et al. Genetic and phenotypic
intra-species variation in Candida albicans. Genome Res. 2015; 25(3): 413-25. DOI: https://doi.
org/10.1101/gr.174623.114
Raz-Pasteur A, Ullmann Y, Berdicevsky I. The pathogenesis of Candida infections in a human skin model:
scanning electron microscope observations. SRN Dermatol. 2011; 2011: 150642. DOI: https://doi.
org/10.5402/2011/150642
Laronde DM, Williams PM, Hislop TG, Poh C, Ng S, Zhang L et al. Decision making on detection and
triage of oral mucosa lesions in community dental practices: screening decisions and referral. Community
Dent Oral Epidemiol. 2014; 42(4): 375-84. DOI: https://doi.org/10.1111/cdoe.12093
Roberts CL, Algert CS, Rickard KL, Morris JM. Treatment of vaginal candidiasis for the prevention of
preterm birth: a systematic review and meta-analysis. Syst Rev. 2015; 4: 31. DOI: https://doi.org/10.1186/
s13643-015-0018-2
Balan P, Gogineni S, Kumari NS, Shetty V, Lakshman-Rangare A, Castelino R et al.
Candida
carriage rate
and growth characteristics of saliva in Diabetes Mellitus patients: a case-control study. J Dent Res Dent
Clin Dent Prospects. 2015; 9(4): 274-9. DOI: https://doi.org/10.15171/joddd.2015.048
Kok ET, Jong MC, Gravendeel B, Van-Leeuwen WB, Baars EW. Resistance to antibiotics and antifungal
medicinal products: can complementary and alternative medicine help solve the problem in common
infection diseases? The introduction of a Dutch research consortium. Evid Based Complement Alternat
Med. 2015; 2015: 521584. DOI: https://doi.org/10.1155/2015/521584
Komeno Y, Uryu H, Iwata Y, Hatada Y, Sakamoto J, Iihara K et al. Esophageal candidiasis as the
initial manifestation of acute myeloid leukemia. Intern Med. 2015; 54(23): 3087-92. DOI: https://doi.
org/10.2169/internalmedicine.54.4613
Meighani G, Aghamohammadi A, Javanbakht H, Abolhassani H, Nikayin S, Jafari SM et al. Oral and dental
health status in patients with primary antibody deficiencies. Iran J Allergy Asthma Immunol. 2011; 10(4):
-93. DOI: https://doi.org/010.04/ijaai.289293
Lagman R, Davis M, LeGrand S, Walsh D, Parala A, Gamier P, et al. Single-Dose Fluconazole Therapy for
Oral Thrush in Hospice and Palliative Medicine Patients. Am J Hosp Palliat Care. 2017 Aug; 34(7): 645-9.
DOI: 10.1177/1049909116643927
Lara HH, Romero-Urbina DG, Pierce C, Lopez-Ribot JL, Arellano-Jiménez MJ, Jose-Yacaman M. Effect of
silver nanoparticles on Candida albicans biofilms: an ultrastructural study. J Nanobiotechnology. 2015; 13:
DOI: https://doi.org/10.1186/s12951-015-0147-8
Akbari F, Kjellerup BV. Elimination of bloodstream infections associated with Candida albicans
biofilm in intravascular catheters. Pathogens. 2015; 4(3): 457-69. DOI: ttps://doi.org/10.3390/pathogens4030457
Paula SB, Morey AT, Santos JP, Santos PM, Gameiro DG, Kerbauy G et al. Oral Candida colonization in
HIV-infected patients in Londrina-PR, Brazil: antifungal susceptibility and virulence factors. J Infect Dev
Ctries. 2015; 9(12): 1350-9. DOI: https://doi.org/10.3855/jidc.6970
Popova EV, Dermendjieva SI, Vangelova RP. Quantity determination of T- and B-leucocytes in peripheral
blood in patients with Candida induced subprosthetic stomatitis. Folia Med (Plovdiv). 2001; 43(1-2): 50-2.
Garcia-Cuesta C, Sarrion-Pérez MG, Bagán JV. Current treatment of oral candidiasis: A literature review. J
Clin Exp Dent. 2014: 1; 6(5): e576-82. DOI: https://doi.org/10.4317/jced.51798
Thomson DD, Berman J, Brand AC. High frame-rate resolution of cell division during
Candida albicans filamentation. Fungal Genet Biol. 2016; 88: 54-8. https://doi.org/10.1016/j.fgb.2016.02.001
Epstein JB, Thariat J, Bensadoun RJ, Barasch A, Murphy BA, Kolnick L, et al. Oral complications of cancer
and cancer therapy: from cancer treatment to survivorship. CA Cancer J Clin. 2012 Nov-Dec; 62(6): 400-22.
DOI: 10.3322/caac.21157.
Rabagliati R, Fuentes G, Guzmán AM, Orellana E, Oporto J, Aedo I et al. Enfermedad fúngica invasora
en pacientes hemato-oncológicos y receptores de trasplante de precursores hematopoyéticos bajo la
perspectiva de los criterios diagnósticos EORTC/MSG. Rev Chil Infect. 2009; 26(3): 212-9. DOI: http://
dx.doi.org/10.4067/S0716-10182009000400002
Puig-Asensio M, Ruiz-Camps I, Fernández-Ruiz M, Aguado JM, Muñoz P, Valerio M et al. Epidemiology
and outcome of candidaemia in patients with oncological and haematological malignancies: results from
a population-based surveillance in Spain. Clin Microbiol Infect. 2015; 21(5): 491.e1-10. DOI: https://doi.
org/10.1016/j.cmi.2014.12.027
Shrestha M, Boaz K, Srikant N, Shakya A. An assessment of candidal colonization and species differentiation
in head and neck cancer patients receiving radiation. J Nepal Health Res Counc. 2014; 12(3): 156-61.
Krishnan PA. Fungal infections of the oral mucosa. Indian J Dent Res. 2012; 23(5): 650-9. DOI: https://doi.
org/10.4103/0970-9290.107384
Verma SP, Dubashi B, Narayanan P, Basu D, Dutta TK, Dhanraj KM. A case of pediatric acute lymphoblastic
leukemia with invasive candidiasis: short review. Indian J Hematol Blood Transfus. 2014; 30(Suppl 1): 101-
DOI: https://doi.org/10.1007/s12288-013-0274-z
Morais EF, Lira JA, Macedo RA, Santos KS, Elias CT, Morais-Mde L. Oral manifestations resulting from
chemotherapy in children with acute lymphoblastic leukemia. Braz J Otorhinolaryngol. 2014; 80(1): 78-85.
DOI: https://doi.org/10.5935/1808-8694.20140015
Ramla S, Sharma V, Patel M. Influence
of cancer treatment on the Candida albicans isolated from the oral
cavities of cancer patients. Support Care Cancer. 2016; 24(6): 2429-36. DOI: https://doi.org/10.1007/
s00520-015-3035-8
Ueta E, Tanida T, Yoneda K, Yamamoto T, Osaki T. Increase of Candida cell virulence by anticancer drugs
and irradiation. Oral Microbiol Immunol. 2001; 16(4): 243-9.
Belazi M, Velegraki A, Koussidou-Eremondi T, Andreadis D, Hini S, Arsenis G et al. Oral Candida isolates
in patients undergoing radiotherapy for head and neck cancer: prevalence, azole susceptibility profiles and
response to antifungal treatment. Oral Microbiol Immunol. 2004; 19(6): 347-51.
Cornely O A, Maertens J, Winston D J, Perfect J, Ullman A J, Walsh T J, et al. Posaconazole
vs fluconazole
or itraconazole prophylaxis in patients with neutropenia. N Engl J Med. 2007; 356(4): 348-59. DOI: https://
doi.org/10.1056/NEJMoa061094
Siwek GT, Dodgson KJ, de-Magalhaes-Silverman M, Bartelt LA, Kilborn SB, Hoth PL et al. Invasive
zygomycosis in hematopoietic stem cell transplant recipients receiving voriconazole prophylaxis. Clin
Infect Dis. 2004; 39(4): 584-7. DOI: https://doi.org/10.1086/422723
Pizzo PA, Robichaud KJ, Gill FA, Witebsky FG. Empiric antibiotic and antifungal therapy for cancer patients
with prolonged fever and granulocytopenia. Am J Med. 1982; 72(1): 101-11.
Pemán J, Zaragoza R, Quindós G, Alkorta M, Cuétara MS, Camarena JJ et al. Clinical factors associated
with a Candida albicans Germ Tube Antibody positive test in Intensive Care Unit patients. BMC Infect Dis.
; 11: 60. DOI: https://doi.org/10.1186/1471-2334-11-60
Paz M, Kahl S, Escovich L, Garófalo F, Bulacio L, López C. Presencia de hongos levaduriformes en cavidad
oral en pacientes con tratamiento oncológico por cáncer de cabeza y cuello. Caracterización fenotípica.
Estudio piloto. Anuario Fundación Dr. J.R. Villavicencio. 2007; 15: 141-6.
Tosun I, Aydin F, Kaklikkaya N, Erturk M. Induction of secretory aspartyl proteinase of Candida albicans by
HIV-1 but not HSV-2 or some other microorganisms associated with vaginal environment. Mycopathologia.
; 159(2): 213-8. DOI: https://doi.org/10.1007/s11046-004-2226-5
Konopka T, Dembowska E, Pietruska M, Dymalski P, Górska R. Periodontal status and selected parameters
of oral condition of Poles aged 65 to 74 years. Przegl Epidemiol. 2015; 69(3): 537-42.
Sun H, Chen Y, Zou X, Li H, Yin X, Qin H, et al. Occurrence of oral Candida colonization and its risk factors
among patients with malignancies in China. ClinOralInvestig. 2016 Apr; 20(3): 459-67. DOI: 10.1007/
s00784-015-1524-2
Ramage G, Vandewalle K, Wickes BL, López-Ribot JL. Characteristics of biofilm formation by Candida
albicans. Rev Iberoam Micol. 2001; 18(4): 163-70.
Pulido M, Carmona M, Abud K, Bolivar K, Cortés Y. Presencia de Candida en pacientes con
estomatitis subprotésica que acuden a la facultad de odontología de la Universidad de Cartagena en
el periodo transcurrido entre agosto 2006-junio 2007. Duazary. 2008; 5(2): 90-8. DOI: http://dx.doi.
org/10.21676/2389783X.660
Rebolledo M, Pastor M. Comportamiento de prótesis dentales removibles como factor causal de
estomatitis subprotésica: Reporte de un caso. Act Odont Col. 2012; 2(2): 105-11. DOI: http://dx.doi.
org/10.15446/aoc
Li X, Hou Y, Yue L, Liu S, Du J, Sun S. Potential targets for antifungal drug discovery based on growth and
virulence in Candida albicans. Antimicrob Agents Chemother. 2015; 59(10): 5885-91. DOI: https://doi.
org/10.1128/AAC.00726-15
Casnati BE, Papone V, Cuestas M, Lorenzo S, Alvarez R, Massa F. Valoración del tratamiento local de la
candidosis oral. Correlación etiológica. Odontoestomatología. 2011; 13(18): 66-75.
Downloads
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2018 Revista Facultad de Odontología Universidad de Antioquia
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Copyright Notice
Copyright comprises moral and patrimonial rights.
1. Moral rights: are born at the moment of the creation of the work, without the need to register it. They belong to the author in a personal and unrelinquishable manner; also, they are imprescriptible, unalienable and non negotiable. Moral rights are the right to paternity of the work, the right to integrity of the work, the right to maintain the work unedited or to publish it under a pseudonym or anonymously, the right to modify the work, the right to repent and, the right to be mentioned, in accordance with the definitions established in article 40 of Intellectual property bylaws of the Universidad (RECTORAL RESOLUTION 21231 of 2005).
2. Patrimonial rights: they consist of the capacity of financially dispose and benefit from the work trough any mean. Also, the patrimonial rights are relinquishable, attachable, prescriptive, temporary and transmissible, and they are caused with the publication or divulgation of the work. To the effect of publication of articles in the journal Revista de la Facultad de Odontología, it is understood that Universidad de Antioquia is the owner of the patrimonial rights of the contents of the publication.
The content of the publications is the exclusive responsibility of the authors. Neither the printing press, nor the editors, nor the Editorial Board will be responsible for the use of the information contained in the articles.
I, we, the author(s), and through me (us), the Entity for which I, am (are) working, hereby transfer in a total and definitive manner and without any limitation, to the Revista Facultad de Odontología Universidad de Antioquia, the patrimonial rights corresponding to the article presented for physical and digital publication. I also declare that neither this article, nor part of it has been published in another journal.
Open Access Policy
The articles published in our Journal are fully open access, as we consider that providing the public with free access to research contributes to a greater global exchange of knowledge.
Creative Commons License
The Journal offers its content to third parties without any kind of economic compensation or embargo on the articles. Articles are published under the terms of a Creative Commons license, known as Attribution – NonCommercial – Share Alike (BY-NC-SA), which permits use, distribution and reproduction in any medium, provided that the original work is properly cited and that the new productions are licensed under the same conditions.
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.